Årsaker til atopisk eksem

Dette dokumentet er basert på det profesjonelle dokumentet Atopisk eksem. Referanselisten for dette dokumentet vises nedenfor.

1. Eichenfield LF, Boguniewicz M, Simpson EL, et al. Translating atopic dermatitis management guidelines into practice for primary care providers. Pediatrics. Published online August 3, 2015. doi: 10.1542/peds.2014-3678 DOI 
2. Simons FE; Early Prevention of Asthma in Atopic Children Study Group. H1-antihistamine treatment in young atopic children: effect on urticaria. Ann Allergy Asthma Immunol 2007; 99: 261-6. PubMed 
3. Weston WL, Howe W. Pathogenesis, clinical manifestations, and diagnosis of atopic dermatitis (eczema). UpToDate, last updated Mar 20, 2017. www.uptodate.com 
4. Vinding GR, Zarchi K, Ibler KS, et al. Is adult atopic eczema more common than we think? - A population-based study in Danish adults. Acta Derm Venereol 2014; 94:480. PubMed 
5. Mortz CG, Andersen KE, Dellgren C, et al. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy 2015; 70:836. PubMed 
6. Hebert AA, Grabell DA. Atopic dermatitis. BestPractice, last reviewed 7 Sept 2020. bestpractice.bmj.com 
7. Mohn CH, Blix HS, Halvorsen JA et al. Incidence Trends of Atopic Dermatitis in Infancy and Early Childhood in a Nationwide Prescription Registry Study in Norway. JAMA Netw Open 2018. doi:10.1001/jamanetworkopen.2018.4145 DOI 
8. Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc. 2019;40(2):84-92. PubMed 
9. van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: A systematic review. J Allergy Clin Immunol 2007; 120: 565-9. PubMed 
10. Spergel JM, Boguniewicz M, Schneider L et al. Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements. Pediatrics 2015; 136: e1530-8. pmid:26598458 PubMed 
11. Fiocchi A, Brozek J, Schünemann H, et.al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol 2010; Suppl 21: 1-125.
12. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014; 70:338. PubMed 
13. Langeland T. Lokalbehandling av atopisk dermatitt med kalcineurinhemmere. Tidsskr Nor Lægeforen 2006; 126: 321-2. Tidsskrift for Den norske legeforening 
14. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD000133. Cochrane (DOI) 
15. Skjerven HO, Rehbinder EM, Vettukattil R, et al. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial. Lancet 2020. doi:10.1016/S0140-6736(19)32983-6 DOI 
16. van den Oord RAHM, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009; 339: b2433. BMJ (DOI) 
17. Elyas A. Bradley M. Viktigt att beakta att hudåkommor kan variera beroende på hudtyp. Läkartidningen. 2021,118:20208. lakartidningen.se 
18. Helsedirektoratet (2021). Nasjonal faglig retningslinje for antibiotika i primærhelsetjenesten nettdokument. Oslo: Helsedirektoratet (sist faglig oppdatert 16. november 2021, lest jan 2022).
19. Milingou M, Tagka A, Armenaka M, et al. Patch tests in children: a review of 13 years of experience in comparison with previous data. Pediatr Dermatol. 2010 ;27:255-259.
20. Tollefson MM, Bruckner AL. Atopic dermatitis: Skin directed management. Pediatrics 2014. doi:10.1542/peds.2014-2812 DOI 
21. Løvold Berents T, Kurås Skram M. Atopisk eksem. Generell veileder i pediatri, Norsk barnelegeforening. Sist revidert 2018. www.helsebiblioteket.no 
22. Nankervis H, Thomas KS, Delamere FM, Barbarot S, Rogers NK, Williams HC. Scoping systematic review of treatments for eczema. Southampton (UK): NIHR Journals Library; 2016 May. PMID: 27280278. PubMed 
23. Yin ZQ, Zhang WM, Song GX, et al. Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis. J Dermatol. 2012;39:520-526. PubMed 
24. Strober B, Mallya UG, Yang M, et al. Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis 1-Year Results From the RELIEVE-AD Study. JAMA Dermatol 2022. PMID: 34910086 PubMed 
25. Silverberg JI, Simpson EL, Wollenberg A, et al. Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders An Extension Study of 2 Randomized Clinical Trials. JAMA Dermatol 2021. pmid:33978711 PubMed 
26. Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2010;24:317-328. PubMed 
27. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-22. PMID: 26377142. PubMed 
28. van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD012119. pmid: 28166390 PubMed 
29. Santer M, Ridd MJ, Francis NA, et al. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness. BMJ 2018; 361: k1332. pmid:26525422 PubMed 
30. Matterne U, Böhmer MM, Weisshaar E. Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD012167. DOI: 10.1002/14651858.CD012167.pub2. The Cochrane Library 
31. Relis database. Medikamentvalg ved allergiske reaksjoner hos barn under 2 år. 17.10.2014.
32. Relis database. Behandling av urtikaria hos barn under 12 måneder. 15.10.2014.
33. Green C, Colquitt JL, Kirby J, Davidson P. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol 2005; 152: 130-41. PubMed 
34. Cury Martins J, Martins C, Aoki V, et al. Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev. 2015 Jul 1;7:CD009864. PMID: 26132597 PubMed 
35. Sigurgeirsson B, Boznanski A, Todd G, et al. Safety and efficacy of pimecrolimus in atopic dermatitis: A 5-year randomized trial. Pediatrics 2015; 135: 597-606. doi:10.1542/peds.2014-1990 DOI 
36. Paller AS, Lebwohl M, Fleischer AB, and the US/Canada Tacrolimus Ointment Study Group. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies. J Am Acad Dermatol 2005; 52: 810-22. PubMed 
37. Lam M, Zhu JW, Tadrous M, Drucker AM. Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma: A Systematic Review and Meta-analysis. JAMA Dermatol. 2021 May 1;157(5):549-558. PMID: 33787818 PubMed 
38. Norsk forening for dermatologi og venerologi. Veiledende anbefalinger for bruk av biologiske legemidler og JAK-hemmer ved atopisk eksem. Versjon 3.0. Oslo; 15.09.2021. www.legeforeningen.no 
39. Silverberg JI, Yosipovitch G, Simpson EL, et al. Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS. J Am Acad Dermatol. 2020;82(6):1328-1336. PMID: 32135208. PubMed 
40. Sawangjit R, Dilokthornsakul P, Lloyd-Lavery A, Lai NM, Dellavalle R, Chaiyakunapruk N. Systemic treatments for eczema: a network meta‐analysis. Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No.: CD013206. DOI: 10.1002/14651858.CD013206.pub2. DOI 
41. Drucker AM, Morra DE, Prieto-Merino D et al. Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis. JAMA Dermatol. 2022 Mar 16. Epub ahead of print. PMID: 35293977. PubMed 
42. Eichenfield LF, Flohr C, Sidbury R, et al. Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis The JADE TEEN Randomized Clinical Trial. JAMA Dermatol 2021. pmid:34406366 PubMed 
43. Chan S, Cornelius V, Cro S, et al. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial. JAMA Pediatr. 2019 Nov 25. pii: 2755655. PMID: 31764962 PubMed 
44. Bae JM, Choi YY, Park CO, et al. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2013 Jul;132(1):110-7. doi: 10.1016/j.jaci.2013.02.044. Epub 2013 May 3.
45. Gendelman SR, Lang DM. Sublingual immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system. Curr Allergy Asthma Rep. 2015;15:498. doi: 10.1007/s11882-014-0498-5 DOI 
46. Chang Y-S, Trivedi MK, Jha A, et al. Synbiotics for prevention and treatment of atopic dermatitis: A meta-analysis of randomized clinical trials. JAMA Pediatr 2016. doi: 10.1001/jamapediatrics.2015.3943 DOI 
47. Makrgeorgou A, Leonardi-Bee J, Bath-Hextall FJ et al. Probiotics for treating eczema. Cochrane Database Syst Rev 2018. doi:10.1002/14651858.CD006135.pub3. DOI 
48. Francis NA, Ridd MJ, Thomas-Jones E, et al. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study.. Health Technol Assess 2016; 20: 1-84. doi:10.3310/hta20190 DOI 
49. Ortiz-Salvador JM, Pérez-Ferriols A. Phototherapy in Atopic Dermatitis. Adv Exp Med Biol. 2017;996:279-286. PMID: 29124708. PubMed 
50. Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014 Oct;134(4):818-23. PubMed 
51. Greer FR, Sicherer SH, Burks AW; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: The role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008; 121: 183-91. Pediatrics 
52. Hoyt AE, Medico T, Commins SP. Breast Milk and Food Allergy: Connections and Current Recommendations. Pediatr Clin North Am. 2015;62:1493-507. pmid:26456446 PubMed 
53. Alexander DD, Cabana MD. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. J Pediatr Gastroenterol 2010; 50: 422-30. PubMed 
54. Boyle RJ, Ierodiakonou D, Khan T, et al. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysis. BMJ 2016; 352: i974. doi:10.1136/bmj.i974 DOI 
55. Yang W, Tu R, Hu Y, et al. Probiotics supplement for the prevention of eczema in children: Study protocol for a meta-analysis and systematic review. Medicine (Baltimore). 2019 Aug;98(34):e16957. PMID: 31441896 PubMed 
56. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121: 116-21. PubMed 
57. Grüber C, van Stuijvenberg M, Mosca F, et al, for the MIPS 1 Working Group. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010; 126: 791-7. PubMed 
58. Lowe KE, Mansfield KE, Delmestri A, et al. Atopic eczema and fracture risk in adults: A population-based cohort study. J Allergy Clin Immunol 2019. doi:10.1016/j.jaci.2019.09.015 DOI 
59. Maintz L, Welchowski T, Herrmann N et al. Machine Learning-Based Deep Phenotyping of Atopic Dermatitis: Severity-Associated Factors in Adolescent and Adult Patients. JAMA Dermatol. 2021 Nov 10:e213668. doi: 10.1001/jamadermatol.2021.3668. Epub ahead of print. PMID: 34757407 PubMed 
60. Blauvelt A, de Bruin-Weller M, Gooderham M et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): A 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. The Lancet 2017; 389: 2287-303. pmid:28478972 PubMed 
61. Blauvelt A, Teixeira HD, Simpson EL, et al. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol 2021; 157:1047. PubMed